Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -1.40% | -4.95% | +19.89% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 14-01-26 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-20 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Chief Tech/Sci/R&D Officer | - | 18-12-31 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | 55 | Feb. 05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Ian Clark
BRD | Director/Board Member | 62 | 17-01-02 |
Terry Gould
BRD | Director/Board Member | 67 | 14-10-31 |
Peter Thompson
FOU | Founder | 64 | 14-01-26 |
Linda Grais
BRD | Director/Board Member | 68 | 19-01-27 |
Scott Morrison
BRD | Director/Board Member | 66 | 15-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 62,551,281 | 56,761,695 ( 90.74 %) | 0 | 90.74 % |
Company contact information
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.59% | 134M | |
+49.21% | 56.87B | |
+35.20% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- CRVS Stock
- Company Corvus Pharmaceuticals, Inc.